Valuation: Cochlear Limited

Capitalization 1.79TCr 1.23TCr 1.05TCr 969.52Cr 906Cr 1.69TCr 1,13000Cr 11TCr 4.4TCr 53TCr 4.61TCr 4.52TCr 1,94100Cr P/E ratio 2026 *
45.4x
P/E ratio 2027 * 36.4x
Enterprise value 1.76TCr 1.21TCr 1.03TCr 951.26Cr 888.93Cr 1.66TCr 1,10900Cr 11TCr 4.32TCr 52TCr 4.52TCr 4.43TCr 1,90400Cr EV / Sales 2026 *
6.79x
EV / Sales 2027 * 6.09x
Free-Float
99.53%
Yield 2026 *
1.71%
Yield 2027 * 2%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.82%
1 week+1.94%
Current month+5.01%
1 month+4.49%
3 months-5.68%
6 months-12.83%
Current year+5.01%
More quotes
1 week 265
Extreme 265
276.74
1 month 258
Extreme 258
276.74
Current year 258
Extreme 258
276.74
1 year 246.14
Extreme 246.14
323
3 years 202.2
Extreme 202.2
350.31
5 years 178.54
Extreme 178.545
350.31
10 years 89.97
Extreme 89.97
350.31
More quotes
Manager TitleAgeSince
Chief Executive Officer - 03/01/2018
Chief Tech/Sci/R&D Officer - 01/07/2019
Chief Tech/Sci/R&D Officer - 01/02/2023
Director TitleAgeSince
Chairman 58 21/08/2021
Director/Board Member - 14/11/2017
Director/Board Member 69 13/12/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.82%+1.94%-13.22%+34.57% 1.23TCr
-1.39%-2.82%-26.13%-20.44% 1.95TCr
-0.81%+1.24%-31.00%-5.73% 1.67TCr
-2.99%-2.99% - - 489.05Cr
-0.31%-2.15%-6.18%-8.46% 214.68Cr
+2.50%-0.97%-36.59%-51.65% 175.18Cr
+0.88%+3.52%+30.59%-39.07% 151.43Cr
+1.37%-0.39%+27.03%+79.51% 62Cr
-4.91%+6.36%+26.68% - 38Cr
-4.10%+1.54%-34.19%+173.51% 37Cr
Average -1.06%+0.17%-7.00%+20.28% 601.93Cr
Weighted average by Cap. -1.04%-0.37%-21.82%-2.28%
See all sector performances

Financials

2026 *2027 *
Net sales 258.77Cr 177.77Cr 151.2Cr 140.14Cr 130.96Cr 244.14Cr 16TCr 1.6TCr 635.86Cr 7.71TCr 666.59Cr 652.96Cr 28TCr 287.95Cr 197.82Cr 168.25Cr 155.95Cr 145.73Cr 271.67Cr 18TCr 1.78TCr 707.56Cr 8.58TCr 741.76Cr 726.59Cr 31TCr
Net income 39Cr 27Cr 23Cr 21Cr 20Cr 37Cr 2.46TCr 241.16Cr 96Cr 1.16TCr 100.37Cr 98Cr 4.22TCr 49Cr 34Cr 29Cr 27Cr 25Cr 46Cr 3.1TCr 304.46Cr 120.87Cr 1.47TCr 126.71Cr 124.12Cr 5.33TCr
Net Debt -34Cr -23Cr -20Cr -18Cr -17Cr -32Cr -2.13TCr -208.71Cr -83Cr -1TCr -87Cr -85Cr -3.66TCr -36Cr -25Cr -21Cr -20Cr -18Cr -34Cr -2.3TCr -225.87Cr -90Cr -1.09TCr -94Cr -92Cr -3.96TCr
More financial data * Estimated data
Logo Cochlear Limited
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services, and Acoustics. Cochlear Implants segment offers Cochlear implant systems. Services segment offers sound processor upgrades, accessories and other. Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Its Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Employees
5,500
More about the company
Date Price Change Volume
23/26/23 273.73 $ -0.82% 1,88,818
22/26/22 275.99 $ +2.14% 1,24,388
21/26/21 270.22 $ +0.19% 1,02,526
20/26/20 269.72 $ +0.39% 1,29,745
19/26/19 268.68 $ +0.06% 99,655

Delayed Quote Australian S.E., January 23, 2026 at 10:41 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
273.73AUD
Average target price
303.71AUD
Spread / Average Target
+10.95%
Consensus

Quarterly revenue - Rate of surprise